Get started
Author

Peng Lin

ORCID: 0000-0002-8544-9012
Observed ORCID: 0000-0002-8544-9012
OpenAlex ID: A5038993188
Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma
2018 · Binghao Li, Zhan Wang, et al. · Cancer Research · 109
Prognostic factors for survival among patients with primary bone sarcomas of small bones
2018 · Zhan Wang, Shu Li, et al. · Cancer Management and Research · 28
PDF
Surgical Options for Aggressive Vertebral Hemangiomas：A case series, literature review and treatment recommendations
2023 · Mohamed Diaty Diarra, Zengjie Zhang, et al. · Journal of bone oncology · 10
Does composite bone resection for soft-tissue sarcoma with cortical contact result in better local control and survival compared to sub-periosteal dissection?
2025 · Hao Qu, Keyi Wang, et al. · Bone & Joint Open · 2
Kinesin light chain 1 stabilizes insulin receptor substrate 1 to regulate the IGF‐1‐AKT signaling pathway during myoblast differentiation
2024 · Zihao Qu, Linjing Shi, et al. · The FASEB Journal · 1
Figure S2 from Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma
2024 · Binghao Li, Guoqi Li, et al.
Data from Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma
2024 · Binghao Li, Guoqi Li, et al.
Figure S7 from Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma
2024 · Binghao Li, Guoqi Li, et al.
Supplementary Table 2 from Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma
2024 · Binghao Li, Guoqi Li, et al.
Figure S1 from Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma
2024 · Binghao Li, Guoqi Li, et al.
Figure S4 from Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma
2024 · Binghao Li, Guoqi Li, et al.
Figure S6 from Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma
2024 · Binghao Li, Guoqi Li, et al.
Figure S5 from Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma
2024 · Binghao Li, Guoqi Li, et al.
Supplementary Table 1 from Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma
2024 · Binghao Li, Guoqi Li, et al.
Figure S3 from Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma
2024 · Binghao Li, Guoqi Li, et al.
Genomic profiling of non-small cell lung cancer with rare aberrations in EGFR codon L858 and the survival outcome under real-world first-line EGFR tyrosine kinase inhibitor treatment compared to classic EGFRL858R.
2024 · Hengyuan Li, Jingying Zhang, et al. · Journal of Clinical Oncology
Data from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma
2023 · Binghao Li, Zhan Wang, et al.
Figure S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma
2023 · Binghao Li, Zhan Wang, et al.
Table S2 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma
2023 · Binghao Li, Zhan Wang, et al.
Figure S4 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma
2023 · Binghao Li, Zhan Wang, et al.
Table S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma
2023 · Binghao Li, Zhan Wang, et al.
PDF
Figure S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma
2023 · Binghao Li, Zhan Wang, et al.
PDF
Figure S4 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma
2023 · Binghao Li, Zhan Wang, et al.
PDF
Table S1 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma
2023 · Binghao Li, Zhan Wang, et al.
PDF
Table S3 from Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma
2023 · Binghao Li, Zhan Wang, et al.
Works count: 35
Citation count: 149
H-index: 3
I10-index: 3
Year
Topic
Type